vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $21.5M, roughly 1.2× PEOPLES BANCORP OF NORTH CAROLINA INC). PEOPLES BANCORP OF NORTH CAROLINA INC runs the higher net margin — 30.8% vs -54.6%, a 85.4% gap on every dollar of revenue. PEOPLES BANCORP OF NORTH CAROLINA INC produced more free cash flow last quarter ($20.0M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

PEOPLES BANCORP OF NORTH CAROLINA INC is a regional bank holding company headquartered in North Carolina, U.S. It offers a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving local residents, small and medium-sized enterprises, and community organizations across its operating areas in North Carolina.

CBLL vs PEBK — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.2× larger
CBLL
$24.8M
$21.5M
PEBK
Higher net margin
PEBK
PEBK
85.4% more per $
PEBK
30.8%
-54.6%
CBLL
More free cash flow
PEBK
PEBK
$30.9M more FCF
PEBK
$20.0M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
PEBK
PEBK
Revenue
$24.8M
$21.5M
Net Profit
$-13.5M
$6.6M
Gross Margin
87.3%
Operating Margin
-58.9%
40.7%
Net Margin
-54.6%
30.8%
Revenue YoY
5.6%
Net Profit YoY
86.4%
EPS (diluted)
$-0.35
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
PEBK
PEBK
Q4 25
$24.8M
$21.5M
Q3 25
$22.6M
$21.4M
Q2 25
$21.2M
$20.7M
Q1 25
$20.5M
$20.0M
Q4 24
$20.4M
Q3 24
$17.2M
$20.5M
Q2 24
$20.1M
Q1 24
$19.8M
Net Profit
CBLL
CBLL
PEBK
PEBK
Q4 25
$-13.5M
$6.6M
Q3 25
$-13.5M
$3.7M
Q2 25
$-13.6M
$5.2M
Q1 25
$-12.8M
$4.3M
Q4 24
$3.6M
Q3 24
$-10.4M
$4.0M
Q2 24
$4.9M
Q1 24
$3.9M
Gross Margin
CBLL
CBLL
PEBK
PEBK
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Q1 24
Operating Margin
CBLL
CBLL
PEBK
PEBK
Q4 25
-58.9%
40.7%
Q3 25
-64.8%
22.4%
Q2 25
-70.5%
32.2%
Q1 25
-69.3%
28.2%
Q4 24
22.5%
Q3 24
-57.8%
26.0%
Q2 24
31.3%
Q1 24
23.9%
Net Margin
CBLL
CBLL
PEBK
PEBK
Q4 25
-54.6%
30.8%
Q3 25
-59.6%
17.2%
Q2 25
-64.4%
24.9%
Q1 25
-62.4%
21.8%
Q4 24
17.5%
Q3 24
-60.6%
19.3%
Q2 24
24.4%
Q1 24
19.9%
EPS (diluted)
CBLL
CBLL
PEBK
PEBK
Q4 25
$-0.35
$1.21
Q3 25
$-0.37
$0.67
Q2 25
$-0.38
$0.95
Q1 25
$-0.36
$0.79
Q4 24
$0.65
Q3 24
$-1.85
$0.72
Q2 24
$0.89
Q1 24
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
PEBK
PEBK
Cash + ST InvestmentsLiquidity on hand
$159.3M
$58.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$157.1M
Total Assets
$195.8M
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
PEBK
PEBK
Q4 25
$159.3M
$58.1M
Q3 25
$168.5M
Q2 25
$177.4M
Q1 25
$182.7M
Q4 24
$59.3M
Q3 24
$14.1M
$73.2M
Q2 24
Q1 24
Stockholders' Equity
CBLL
CBLL
PEBK
PEBK
Q4 25
$155.3M
$157.1M
Q3 25
$164.1M
$149.5M
Q2 25
$172.2M
$144.0M
Q1 25
$180.9M
$138.5M
Q4 24
$130.6M
Q3 24
$-136.0M
$136.3M
Q2 24
$124.3M
Q1 24
$121.1M
Total Assets
CBLL
CBLL
PEBK
PEBK
Q4 25
$195.8M
$1.7B
Q3 25
$199.5M
$1.7B
Q2 25
$207.7M
$1.7B
Q1 25
$213.5M
$1.7B
Q4 24
$1.7B
Q3 24
$47.1M
$1.7B
Q2 24
$1.7B
Q1 24
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
PEBK
PEBK
Operating Cash FlowLast quarter
$-10.8M
$21.4M
Free Cash FlowOCF − Capex
$-11.0M
$20.0M
FCF MarginFCF / Revenue
-44.2%
92.7%
Capex IntensityCapex / Revenue
0.7%
6.6%
Cash ConversionOCF / Net Profit
3.22×
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$34.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
PEBK
PEBK
Q4 25
$-10.8M
$21.4M
Q3 25
$-11.1M
$4.7M
Q2 25
$-7.5M
$5.5M
Q1 25
$-11.4M
$5.9M
Q4 24
$20.6M
Q3 24
$4.9M
Q2 24
$6.7M
Q1 24
$3.7M
Free Cash Flow
CBLL
CBLL
PEBK
PEBK
Q4 25
$-11.0M
$20.0M
Q3 25
$-11.5M
$4.4M
Q2 25
$-7.6M
$5.4M
Q1 25
$-11.6M
$5.2M
Q4 24
$20.0M
Q3 24
$4.7M
Q2 24
$6.6M
Q1 24
$3.5M
FCF Margin
CBLL
CBLL
PEBK
PEBK
Q4 25
-44.2%
92.7%
Q3 25
-50.8%
20.4%
Q2 25
-35.9%
25.9%
Q1 25
-56.4%
25.8%
Q4 24
98.0%
Q3 24
22.9%
Q2 24
32.7%
Q1 24
17.9%
Capex Intensity
CBLL
CBLL
PEBK
PEBK
Q4 25
0.7%
6.6%
Q3 25
1.6%
1.5%
Q2 25
0.3%
0.5%
Q1 25
0.7%
3.8%
Q4 24
2.9%
Q3 24
1.0%
Q2 24
0.4%
Q1 24
0.6%
Cash Conversion
CBLL
CBLL
PEBK
PEBK
Q4 25
3.22×
Q3 25
1.27×
Q2 25
1.06×
Q1 25
1.36×
Q4 24
5.78×
Q3 24
1.24×
Q2 24
1.36×
Q1 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

PEBK
PEBK

Segment breakdown not available.

Related Comparisons